LENZ THERAPEUTICS, INC. Current Liabilities
LENZ THERAPEUTICS, INC. (LENZ) had Current Liabilities of $17.21 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Liabilities, Current $17.21M.
- 2026-03-31: Liabilities, Current $25.81M.
- 2025-12-31: Liabilities, Current $21.19M.
- 2025-09-30: Liabilities, Current $16.32M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $17.21M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $25.81M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $21.19M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $16.32M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $10.40M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $8.57M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $10.41M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $7.71M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $8.58M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $18.89M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $18.51M 10-K · filed 2025-03-19 | $4.80M 10-K · filed 2024-02-27 |
| 2023-09-30 | $12.54M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $12.27M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $14.34M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $13.04M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $13.52M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $12.07M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $12.77M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.14M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $11.27M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $7.86M 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $32.05M 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |